92056 ⎘
Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups having unsaturation outside the aromatic rings
METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF
#2ECHINOCANDIN-BASED DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#3CANNABIGEROLIC ACID (CDGA) DERIVATIVES AND USES THEREOF
#4SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF
#5EBNA1 inhibitors and their method of use
#6CANNABINOID DERIVATIVES
#7COMPOSITIONS AND METHODS FOR IMMUNE MODULATION AND TREATMENT OF CANCER
#8Compounds for use as inhibitors of alternative oxidase or cytochrome bc1 complex
#9Polymer composition
#10EBNA1 inhibitors and their method of use
#11BASE GENERATOR, BASE-REACTIVE COMPOSITION CONTAINING SAID BASE GENERATOR, AND BASE GENERATION METHOD
#12BIO-STABLE CANNABINOID COMPOUNDS AND METHODS FOR ENHANCING THEIR PHYSIOLOGICAL CONCENTRATION
#13Bio-stable cannabinoid compounds and methods for enhancing their physiological concentration
#14EBNA1 inhibitors and their method of use
#15Benzylpropargylether as nitrification inhibitors
#16EBNA1 inhibitors and their method of use
#17POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME
#18Base generator, base-reactive composition containing said base generator, and base generation method
#19Compounds for use as inhibitors of alternative oxidase or cytochrome BC1 complex
#20Compounds and methods for skin repair
#21Cajanine structure analogous compound, preparation method and use
#22Photoaligning materials
#23Compound for treating cartilage disorders
#24Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#25PHENYL-PRENYL DERIVATIVES, OF MARINE AND SYNTHETIC ORIGIN, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS
#26Therapeutic Molecules and Methods-1
#27Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#28PHENYL-PRENYL-ETHER DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS
#29Biaryl carboxylic acid apoptosis promoters
#30Substituted dibenzoic acid derivatives and use thereof
#31Allyloxy and alkyloxy benzoic acid delivery agents
#32Lanthanide metal-organic frameworks and uses thereof
#33Dicarboxylic acid derivatives and their use
#34Cyclopropylacetic acid derivatives and use thereof
#35Cyclopentene compounds
#361,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors
#37Nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
#38Carboxilic acid derivatives
#39Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
#40Dicarboxylic acid derivatives with pharmaceutical properties
#41Process for preparing enantiomerically enriched 2-alkoxy-3-phenylpropionic acids
#42Apoptosis promoters
#43Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#44KCNQ channel modulating compounds and their pharmaceutical use
#45Therapeutic molecules and methods-1
#46Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)
#47Bisphenyl compounds useful as vitamin D3 receptor agonists
#48(2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives
#49Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
#50Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof